Literature DB >> 30199488

Metformin and Pancreatic Cancer Risk in Patients With Type 2 Diabetes.

Chin-Hsiao Tseng1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30199488     DOI： 10.1097/MPA.0000000000001130

Source DB:  PubMed          Journal:  Pancreas        ISSN： 0885-3177            Impact factor:   3.327


× No keyword cloud information.
  4 in total

1.  Metformin alters the duodenal microbiome and decreases the incidence of pancreatic ductal adenocarcinoma promoted by diet-induced obesity.

Authors:  Tien S Dong; Hui-Hua Chang; Meg Hauer; Venu Lagishetty; William Katzka; Enrique Rozengurt; Jonathan P Jacobs; Guido Eibl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-09-23       Impact factor: 4.052

2.  Metformin Use May Increase Risk of Pancreatic Cancer in Diabetic Women: An Analysis of the Korean National Health Insurance Service-National Health Screening Cohort Database.

Authors:  Joungyoun Kim; Yoon-Jong Bae; Hee-Taik Kang
Journal:  Korean J Fam Med       Date:  2022-09-20

3.  Metformin and Biliary Tract Cancer in Patients With Type 2 Diabetes.

Authors:  Chin-Hsiao Tseng
Journal:  Front Oncol       Date:  2020-10-27       Impact factor: 6.244

4.  Relationships are between metformin use and survival in pancreatic cancer patients concurrent with diabetes: A systematic review and meta-analysis.

Authors:  Yu-Qi Shi; Xiao-Chong Zhou; Peng Du; Min-Yue Yin; Lan Xu; Wen-Jie Chen; Chun-Fang Xu
Journal:  Medicine (Baltimore)       Date:  2020-09-11       Impact factor: 1.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.